Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 1
2013 4
2014 7
2015 4
2016 3
2017 6
2018 3
2019 4
2020 5
2021 5
2022 3
2023 4
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Lipoprotein Apheresis Alleviates Treatment-Resistant Peripheral Artery Disease Despite the Normal Range of Atherogenic Lipoproteins: The LETS-PAD Study.
Ueda E, Toya Y, Wakui H, Ishiga K, Kawai Y, Kobayashi R, Kinguchi S, Kanaoka T, Saigusa Y, Mikami T, Yabuki Y, Goda M, Machida D, Fujita T, Haruhara K, Sugano T, Azushima K, Tamura K. Ueda E, et al. Among authors: kobayashi r. J Atheroscler Thromb. 2024 Apr 3. doi: 10.5551/jat.64639. Online ahead of print. J Atheroscler Thromb. 2024. PMID: 38569869 Free article.
Two acute kidney injury episodes after ICI therapy: a case report.
Ishiga K, Kobayashi R, Kanaoka T, Harada J, Kato I, Fujii S, Wakui H, Toya Y, Tamura K. Ishiga K, et al. Among authors: kobayashi r. CEN Case Rep. 2024 Mar 7. doi: 10.1007/s13730-024-00855-5. Online ahead of print. CEN Case Rep. 2024. PMID: 38453804 Free article.
Angiotensin II type 1 receptor-associated protein deletion combined with angiotensin II stimulation accelerates the development of diabetic kidney disease in mice on a C57BL/6 strain.
Taguchi S, Azushima K, Yamaji T, Suzuki T, Abe E, Tanaka S, Hirota K, Tsukamoto S, Morita R, Kobayashi R, Kinguchi S, Yamashita A, Wakui H, Tamura K. Taguchi S, et al. Among authors: kobayashi r. Hypertens Res. 2024 Jan;47(1):55-66. doi: 10.1038/s41440-023-01496-4. Epub 2023 Nov 13. Hypertens Res. 2024. PMID: 37957242
Effects of a High-Protein Diet on Kidney Injury under Conditions of Non-CKD or CKD in Mice.
Tanaka S, Wakui H, Azushima K, Tsukamoto S, Yamaji T, Urate S, Suzuki T, Abe E, Taguchi S, Yamada T, Kobayashi R, Kanaoka T, Kamimura D, Kinguchi S, Takiguchi M, Funakoshi K, Yamashita A, Ishigami T, Tamura K. Tanaka S, et al. Among authors: kobayashi r. Int J Mol Sci. 2023 Apr 24;24(9):7778. doi: 10.3390/ijms24097778. Int J Mol Sci. 2023. PMID: 37175483 Free PMC article.
Cardiovascular and kidney outcomes of combination therapy with sodium-glucose cotransporter-2 inhibitors and mineralocorticoid receptor antagonists in patients with type 2 diabetes and chronic kidney disease: A systematic review and network meta-analysis.
Tsukamoto S, Morita R, Yamada T, Urate S, Azushima K, Uneda K, Kobayashi R, Kanaoka T, Wakui H, Tamura K. Tsukamoto S, et al. Among authors: kobayashi r. Diabetes Res Clin Pract. 2022 Dec;194:110161. doi: 10.1016/j.diabres.2022.110161. Epub 2022 Nov 17. Diabetes Res Clin Pract. 2022. PMID: 36403681
Deficiency of the kidney tubular angiotensin II type1 receptor-associated protein ATRAP exacerbates streptozotocin-induced diabetic glomerular injury via reducing protective macrophage polarization.
Haruhara K, Suzuki T, Wakui H, Azushima K, Kurotaki D, Kawase W, Uneda K, Kobayashi R, Ohki K, Kinguchi S, Yamaji T, Kato I, Ohashi K, Yamashita A, Tamura T, Tsuboi N, Yokoo T, Tamura K. Haruhara K, et al. Among authors: kobayashi r. Kidney Int. 2022 May;101(5):912-928. doi: 10.1016/j.kint.2022.01.031. Epub 2022 Mar 1. Kidney Int. 2022. PMID: 35240129
52 results